Dejima Pharmacy

Dejima Pharm is a Japanese biotechnology company spun out from Nagasaki University, specializing in the discovery and development of novel therapeutics targeting G protein-coupled receptors (GPCRs) and ion channels. The company utilizes its proprietary Dejima platform to identify small molecule modulators for challenging membrane protein targets that have historically been difficult to drug. Its lead programs focus on high-unmet-need areas such as neuropathic pain and chronic pruritus, leveraging deep expertise in electrophysiology and medicinal chemistry. By bridging academic innovation with industrial drug development, Dejima Pharm aims to deliver first-in-class treatments for sensory, neurological, and cardiovascular disorders.